this presentation will present the pharmacology of the anticoagulant and antiplatelet agents in detail and contain study questions multiple choice with answers in detail according to the famous book of lippincott pharmacology. This chapter describes drugs that are useful in the treatment of disorders of hemostasis. Thrombosis, the formation of an unwanted clot within a blood vessel, is the most common abnormality of hemostasis. Thrombotic disorders include acute myocardial infarction (MI), deep vein thrombosis (DVT), pulmonary embolism (PE), and acute ischemic stroke. These conditions are treated with drugs such as anticoagulants and fibrinolytics. Bleeding disorders related to the failure of hemostasis are less common than thromboembolic disorders. Bleeding disorders include hemophilia, which is treated with transfusion of recombinant factor VIII, and vitamin K deficiency, which is treated with vitamin K supplementation. Figure 21.1 summarizes agents used for the treatment of dysfunctions of hemostasis.

1. PREPARED BY: MUHAMMAD KHOSHKANI

2. I. OVERVIEW MUHAMMAD KHOSHKANI
2

3. MUHAMMAD KHOSHKANI
3

4. II. THROMBUS VERSUS EMBOLUS MUHAMMAD KHOSHKANI
4

5. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
5

6. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
6

7. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
7

8. MUHAMMAD KHOSHKANI
8

9. MUHAMMAD KHOSHKANI
9

10. MUHAMMAD KHOSHKANI
10
BETTER VIEW

11. MUHAMMAD KHOSHKANI
11
BETTER VIEW

12. MUHAMMAD KHOSHKANI
12
BETTER VIEW

13. MUHAMMAD KHOSHKANI
13
BETTER VIEW

14. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
14

15. MUHAMMAD KHOSHKANI
15

16. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
16

17. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
17

18. III. PLATELET RESPONSE TO VASCULER INJURY MUHAMMAD KHOSHKANI
18

19. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
19

20. MUHAMMAD KHOSHKANI
20

21. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
21

22. MUHAMMAD KHOSHKANI
22

23. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
23

24. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
24

25. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
25

26. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
26

27. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
27

28. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
28

29. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
29

30. MUHAMMAD KHOSHKANI
30

31. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
31

32. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
32

33. IV. PLATELET AGGREGATION INHIBITORS MUHAMMAD KHOSHKANI
33

34. V. BLOOD COAGULATION MUHAMMAD KHOSHKANI
34

35. V. BLOOD COAGULATION MUHAMMAD KHOSHKANI
35

36. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
36

37. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
37

38. MUHAMMAD KHOSHKANI
38

39. MUHAMMAD KHOSHKANI
39

40. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
40

41. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
41

42. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
42

43. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
43

44. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
44

45. MUHAMMAD KHOSHKANI
45

46. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
46

47. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
47

48. VI. PARENTERAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
48

49. VII. VITAMIN K ANTAGONISTS MUHAMMAD KHOSHKANI
49

50. VII. VITAMIN K ANTAGONISTS MUHAMMAD KHOSHKANI
50

51. VII. VITAMIN K ANTAGONISTS MUHAMMAD KHOSHKANI
51

52. MUHAMMAD KHOSHKANI
52

53. VII. VITAMIN K ANTAGONISTS MUHAMMAD KHOSHKANI
53

54. VII. VITAMIN K ANTAGONISTS MUHAMMAD KHOSHKANI
54

55. VIII. DIRECT ORAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
55

56. VIII. DIRECT ORAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
56

57. VIII. DIRECT ORAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
57

58. VIII. DIRECT ORAL ANTICOAGULANTS MUHAMMAD KHOSHKANI
58

59. IX. THROMBOLYTIC DRUGS MUHAMMAD KHOSHKANI
59

60. IX. THROMBOLYTIC DRUGS MUHAMMAD KHOSHKANI
60

61. IX. THROMBOLYTIC DRUGS MUHAMMAD KHOSHKANI
61

62. MUHAMMAD KHOSHKANI
62

63. IX. THROMBOLYTIC DRUGS MUHAMMAD KHOSHKANI
63

64. X. DRUGS USED TO TREAT BLEEDING MUHAMMAD KHOSHKANI
64

65. MUHAMMAD KHOSHKANI
65

66. X. DRUGS USED TO TREAT BLEEDING MUHAMMAD KHOSHKANI
66

67. X. DRUGS USED TO TREAT BLEEDING MUHAMMAD KHOSHKANI
67

68. MUHAMMAD KHOSHKANI
68

69. STUDY QUESTIONS MUHAMMAD KHOSHKANI
69

70. STUDY QUESTIONS MUHAMMAD KHOSHKANI
70

71. STUDY QUESTIONS MUHAMMAD KHOSHKANI
71

72. STUDY QUESTIONS MUHAMMAD KHOSHKANI
72

73. STUDY QUESTIONS MUHAMMAD KHOSHKANI
73

74. THANK YOU
‫مەکەن‬ ‫بەشامن‬ ‫بێ‬ ‫خێر‬ ‫دوعای‬ ‫لە‬
74